• Home
  •  > 
  • Product information

Biolimus A9

A new limus-drug designed for stent application provides efficacy*

Drug

  

Lipophilicity comparison
Drug   Lipophilic comparison

 

Precise release kinetics with an initial burst and sustained elution through polymer degradation

Quantity on stent: + 15.6 µg/mm

Nobori - DES Optimal Drug Release
Kinetics Matching Biologic Response to Injury

Nobori - DES Optimal Drug Release Kinetics Matching Biologic Response

Data on file at TERUMO

    

* Chevalier B et al.: Randomised comparison of Nobori®, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial. EuroInterv 2007; 2:426-34

 

Biolimus A9 (™ - by Biosensors)